Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Alamar Biosciences Inc (ALMR)

81 + Investors. Track Smart Money conviction in ALMR. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%

81+

Inst. Holders

Hedge Fund Ownership: ALMR

How many hedge funds hold ALMR — quarterly history vs. share price
Quarterly hedge fund ownership of ALMR vs. share price

Market Analysis: ALMR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ALMR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: ALMR
2026 Q3 Stats Unlock in 9 days 81 + Investors

Track Smart Money conviction in ALMR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 81 0 100%
13F Shares 24M 0 100%
Total Value $582M $0 100%
New Positions 81 0 +81
Increased Positions 0 0 -
Closed Positions 0 0 -
Reduced Positions 0 0 -
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ALMR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

81 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ALMR. Verified SEC 13F-HR filings.

Top 25 ALMR holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Pura Vida Investments, LLC 55.35% 755,909 $20.5M
2 Sands Capital Alternatives, LLC 18.68% 4,230,926 $114.6M
3 Samsara BioCapital, LLC 5.52% 2,480,310 $67.2M
4 Hhlr Advisors, LTD. 3.11% 956,462 $25.9M
5 Braidwell LP 1.09% 1,083,983 $29.4M
6 Avidity Partners Management LP 0.48% 110,000 $3.0M
7 Emerald Advisers, LLC 0.41% 647,183 $17.5M
8 Emerald Mutual Fund Advisers Trust 0.40% 422,127 $11.4M
9 ARK Investment Management LLC 0.24% 1,373,959 $37.2M
10 Deerfield Management Company, L.P. 0.17% 600,000 $16.3M
11 Seven Grand Managers, LLC 0.16% 150,000 $4.1M
12 Burkehill Global Management, LP 0.10% 100,000 $2.7M
13 Palumbo Wealth Management LLC 0.08% 14,532 $394K
14 Ghisallo Capital Management LLC 0.08% 150,000 $4.1M
15 Shay Capital LLC 0.07% 40,000 $1.1M
16 IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.06% 34,742 $941K
17 Bellevue Group AG 0.03% 55,738 $1.5M
18 Artisan Partners Limited Partnership 0.03% 613,744 $16.6M
19 Woodline Partners LP 0.02% 243,320 $6.6M
20 Soros Fund Management LLC 0.02% 60,000 $1.6M
21 Amova Asset Management Americas, Inc. 0.02% 55,800 $1.5M
22 Dymon Asia Capital (singapore) PTE. LTD. 0.02% 16,600 $450K
23 LMR Partners LLP 0.02% 175,000 $4.7M
24 ExodusPoint Capital Management, LP 0.02% 100,691 $2.7M
25 Freestone Grove Partners LP 0.01% 60,000 $1.6M
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Alamar Biosciences Inc (ALMR)

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →